Tofacitinib Solution
Product Images NDC 72205-121

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 72205-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tofacitinib-carton-label (Tofacitinib Carton Label)

Packaging label for Tofacitinib Oral Solution 1 mg/mL by Novadoz Pharmaceuticals LLC. The label includes dosage strength prominently highlighted in yellow, NDC 72205-121-81, volume 240 mL, storage instructions, and contents list including an oral dosing syringe and adapter. Manufacturer MSN Pharmaceuticals Inc. is noted.*

FDA Label Image

Tofacitinib-cntr-label (Tofacitinib Cntr Label)

Label for Tofacitinib Oral Solution 1 mg/mL, an oral liquid prescription drug. The label includes storage instructions, usage guidance, and manufacturer details listing MSN Pharmaceuticals Inc. as manufacturer and Novadoz Pharmaceuticals LLC as distributor. The package size is 240 mL, with directions to dispense an accompanying Medication Guide to patients.*

FDA Label Image

Tofacitinib-figure-07 (Tofacitinib Figure 07)

A line graph comparing the percentage occurrence of disease flare over time from week 18 to week 44 between Tofacitinib 5 mg BID and placebo groups. Data points with error bars indicate disease flare incidence, showing a generally higher occurrence in the placebo group compared to the Tofacitinib group.*

FDA Label Image

Tofacitinib-figure-1 (Tofacitinib Figure 1)

A chart showing pharmacokinetic (PK) ratios and 90% confidence intervals (CI) for intrinsic factors affecting AUC and Cmax of Tofacitinib. Factors include weight, age, sex, race, and renal and hepatic impairment, with ratios plotted relative to reference values along an x-axis ranging from 0 to 4.*

FDA Label Image

Tofacitinib-figure-2 (Tofacitinib Figure 2)

A ratio plot with 90% confidence intervals showing pharmacokinetic parameters (AUC and Cmax) for various coadministered drugs relative to a reference. Drugs include Methotrexate, Midazolam, Levonorgestrel, Ethinyl Estradiol, and Metformin (OCT & MATE Substrate). The x-axis represents the ratio relative to reference, ranging from 0 to 2.*

FDA Label Image

Tofacitinib-figure-3 (Tofacitinib Figure 3)

A pharmacokinetic (PK) chart showing the ratio and 90% confidence intervals (CI) for different coadministered drugs including Ketoconazole, Fluconazole, Rifampin, Methotrexate, Tacrolimus, and Cyclosporine. The chart plots AUC and Cmax values comparing these drug interactions on a horizontal ratio scale from 0 to 2.5.*

FDA Label Image

Tofacitinib-figure-5 (Tofacitinib Figure 5)

A line graph showing response rate (%) over time (months) with visits from 0 to 3 months on the x-axis. It compares two groups: Tofacitinib 5 mg BID (solid line) and Placebo (dashed line), showing higher response rates for Tofacitinib across all visits.*

FDA Label Image

Tofacitinib-os-sy-adap (Tofacitinib Os Sy Adap)

An instructional diagram showing components of Tofacitinib oral solution packaging, including a press-in bottle adapter with ribbed end, a bottle containing the solution, and an oral dosing syringe labeled with barrel, plunger, and oral dosing syringe.*

FDA Label Image

Tofacitinib-step-1 (Tofacitinib Step 1)

An instructional illustration showing Step 1 of using the product, which depicts hands removing a bottle from a carton box as the first step in accessing the oral solution medication.*

FDA Label Image

Tofacitinib-step-10 (Tofacitinib Step 10)

Illustration demonstrating Step 10 of an administration or preparation process, showing how to close the bottle by pushing the cap down and then placing the bottle back into its box. The sequence includes pressing the cap to close the bottle and inserting the bottle into the packaging.*

FDA Label Image

Tofacitinib-step-11 (Tofacitinib Step 11)

An instructional illustration showing Step 11 for cleaning an oral dosing syringe. The image depicts a person rinsing a syringe under running water and moving the plunger up and down to clean it.*

FDA Label Image

Tofacitinib-step-2 (Tofacitinib Step 2)

Instructional illustration showing Step 2 for opening a bottle. The image depicts two hands: one holding the bottle and the other pressing down on the cap while twisting it counterclockwise to open the bottle cap.*

FDA Label Image

Tofacitinib-step-3 (Tofacitinib Step 3)

Instructional illustration showing step 3 to insert a press-in bottle adapter onto the neck of a small bottle. The image depicts hands positioning and pressing the adapter onto the bottle top, indicating proper attachment for dosing or dispensing.*

FDA Label Image

Tofacitinib-step-4 (Tofacitinib Step 4)

An instructional illustration showing a hand holding an oral dosing syringe with the plunger partially pushed, demonstrating the step to remove air from the syringe prior to administration.*

FDA Label Image

Tofacitinib-step-5 (Tofacitinib Step 5)

An instructional illustration showing Step 5 of a dosing procedure, where an oral dosing syringe is being inserted into a small bottle held by a hand.*

FDA Label Image

Tofacitinib-step-6 (Tofacitinib Step 6)

An instructional diagram showing Step 6 for oral solution dosing of Tofacitinib. It depicts a hand withdrawing a dose of the medication from a bottle using a dosing syringe, with an arrow indicating the downward motion of the syringe plunger.*

FDA Label Image

Tofacitinib-step-7 (Tofacitinib Step 7)

An instructional diagram showing Step 7: removing an oral dosing syringe from a small medicine bottle containing Tofacitinib oral solution 1 mg/mL, labeled by Novadoz Pharmaceuticals LLC. The diagram highlights how to properly detach the dosing syringe from the bottle.*

FDA Label Image

Tofacitinib-step-8 (Tofacitinib Step 8)

An instructional illustration labeled "Step 8. Check the dose" showing a hand holding an oral dosing syringe with a close-up inset highlighting the liquid measurement line on the syringe barrel.*

FDA Label Image

Tofacitinib-step-9 (Tofacitinib Step 9)

An instructional diagram showing step 9 for administering Tofacitinib oral solution. It depicts a person taking a dose of the solution using a dosing syringe inserted into their mouth, demonstrating the proper oral intake method.*

FDA Label Image

Tofacitinib-structure (Tofacitinib Structure)

Chemical structure of tofacitinib in its solution form combined with a citric acid component, showing detailed molecular bonds and groups as part of its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.